Viral Vector-Based Modeling of Neurodegenerative Disorders: Parkinson’s Disease

Sep 24, 2016 by in NEUROLOGY Comments Off on Viral Vector-Based Modeling of Neurodegenerative Disorders: Parkinson’s Disease

Model Construct Validity? Reproducible? Progressive nigrostriatal degeneration? Parkinsonian pathology? Parkinsonian symptoms? References Construct validity for idiopathic PD Within group Across groups Striatal DA terminal dysfunction/loss (over weeks) Terminal loss precedes…

read more

Ex Vivo Gene Therapy Using Human Mesenchymal Stem Cells to Deliver Growth Factors in the Skeletal Muscle of a Familial ALS Rat Model

Sep 24, 2016 by in NEUROLOGY Comments Off on Ex Vivo Gene Therapy Using Human Mesenchymal Stem Cells to Deliver Growth Factors in the Skeletal Muscle of a Familial ALS Rat Model

Fig. 1 Ex vivo delivery of growth factor s targeting skeletal muscles for ALS . A GFP-expressing hMSC line was genetically modified by lentiviral infection to stably release growth factors…

read more

MRI-Guided Delivery of Viral Vectors

Sep 24, 2016 by in NEUROLOGY Comments Off on MRI-Guided Delivery of Viral Vectors

Fig. 1 Infusion system setup: This schematic representation demonstrates all of the components in the infusion system. Starting with a 5 mL syringe (1) mounted onto an infusion pump (2),…

read more

Altering Entry Site Preference of Lentiviral Vectors into Neuronal Cells by Pseudotyping with Envelope Glycoproteins

Sep 24, 2016 by in NEUROLOGY Comments Off on Altering Entry Site Preference of Lentiviral Vectors into Neuronal Cells by Pseudotyping with Envelope Glycoproteins

Fig. 1 Entry site preference of pseudotyped lentiviral vectors into neuronal cells. Lentiviral vector pseudotyped with VSV-G mainly enters the cell body areas of neurons, whereas the HiRet/NeuRet vectors with…

read more
Get Clinical Tree app for offline access